Birchtech (BCHT) Stock News

Birchtech (NYSE American: BCHT) issued a shareholder letter outlining 2025 progress and 2026 priorities. Key points: $78 million federal court judgment, ~$37 million in license fees and settlements since 2020, a $15 million capital raise concurrent with an NYSE American listing, early water-market wins including ~$0.9 million in purchase orders, and plans to build a granular activated carbon rejuvenation facility targeting late 2027.

The company highlights expanding licensing, scaling water treatment pilots, and a strategy to grow recurring supply-and-service revenue.

Birchtech (NYSE American: BCHT) priced an underwritten public offering of 6,250,000 common shares at $2.40 per share for aggregate gross proceeds of approximately $15.0 million. The company granted a 30-day option for an additional 937,500 shares to cover over-allotments.

Proceeds will be used for continuing operating expenses, working capital and general corporate purposes. Birchtech’s common stock will begin trading on the NYSE American on or about February 26, 2026, and OTCQB trading will terminate; the TSX listing will remain.

Birchtech (BCHT) announced it expects to uplist its common stock to the NYSE American, with trading to begin on or about February 12, 2026, subject to final NYSE American authorization and continued compliance.

The company also disclosed a concurrent offering of common stock that is conditioned on the NYSE American listing; additional Offering details will be filed with the SEC. Birchtech will remain listed on the TSX and maintain OTCQB quoting until the NYSE American listing becomes effective. Stockholders need take no action prior to the uplisting.

Birchtech (TSX/OTCQB: BCHT) requested enforcement of a $78 million final judgment against the CERT defendants on February 2, 2026. The U.S. District Court of Delaware issued the final judgment on December 29, 2025, after a March 2024 jury verdict.

The 30-day automatic stay has lapsed, allowing immediate enforcement steps; CERT filed a notice of appeal on January 28, 2026, and may seek a bonded stay. Interest on the judgment continues to accrue during appeal.

Birchtech (TSX: BCHT) announced progress on its Carbon Rejuvenation initiative, a thermal reactivation process for spent granular activated carbon (GAC) used in municipal water treatment.

Demonstrations with regulated municipal utilities showed thermally rejuvenated GAC performed comparably to virgin activated carbon in removing PFAS, meeting utility performance benchmarks. The company says the process destroys PFAS and enables GAC reuse, which may lower lifecycle costs, reduce disposal and transport, and support regional deployment aligned with utility sustainability and supply‑chain priorities.

Birchtech Corp (TSX: BCHT; OTCQB: BCHT) announced a 1-for-5 reverse stock split of its common stock effective December 26, 2025, with trading expected to begin on a split-adjusted basis at market open on December 31, 2025. The company said the Reverse Split is intended to increase the per-share price to improve marketability and support a planned uplisting strategy.

Every five issued and outstanding shares will be combined into one share; no fractional shares will be issued because fractional interests will be rounded up. The company’s trading symbol will remain BCHT, but the OTCQB symbol will carry a temporary "D" suffix for 20 business days. Proportional adjustments will be made to equity awards, warrants, and options. Transfer Online will act as exchange agent; no action is required for shares held in brokerage or street name.

Birchtech (TSX:BCHT / OTCQB:BCHT) said a U.S. District Court of Delaware final memorandum opinion led to a proposed final judgment of approximately $78 million after awarding pre-judgment interest compounded quarterly at the prime rate and post-judgment interest; additional interest will accrue daily until paid.

The company noted a prior $57 million jury verdict with a unanimous finding of willful, inducing and contributory infringement, $37 million of license fees and settlements already received, and ongoing consolidated litigation in the Southern District of Iowa with two remaining defendants. The Court ordered a proposed final judgment by December 23, 2025. Management said proceeds will support expansion of mercury emissions licensing and new water purification technologies targeting PFAS removal.

Birchtech (TSX: BCHT / OTCQB: BCHT) will present at the iAccess Alpha Virtual Best Ideas Winter Conference on December 9-10, 2025. President and CEO Richard MacPherson is scheduled for virtual one-on-one investor meetings and will deliver a live presentation on December 9, 2025 at 11:00 a.m. Eastern time. A live audio webcast and archived replay will be available at the conference webcast link. Registration is mandatory for conference participation. Investors and media may request meetings or more information by contacting MZ Group at BCHT@mzgroup.us. Attendees are advised to join at least five minutes early to ensure timely participation.

Birchtech (TSX: BCHT) reported Q3 2025 revenue of $7.4M, up 41% year-over-year, driven by licensing growth, with gross profit of $4.0M (54.8% margin) and net income of $0.8M ($0.01 per share) versus a year-ago loss.

Adjusted EBITDA rose to $1.0M from -$0.5M. Cash on hand was $1.8M with no debt; the company subsequently collected $1.25M in licensing fees after quarter-end. Operationally, Birchtech signed four air-licensing agreements and received ~$0.9M in water business purchase orders, and announced collaboration for RSSCT testing with a national engineering firm.

The company noted a $57M patent infringement verdict with counsel seeking $160M inclusive of enhancements, interest and fees; final judgment is pending. Management will host an earnings call on Nov 13, 2025, 5:00 PM ET.